Differentially expressed cDNAs in PLC beta 3-induced tumor suppression in a human endocrine pancreatic tumor cell line: Activation of the human mismatch repair protein 3 gene

Citation
P. Stalberg et al., Differentially expressed cDNAs in PLC beta 3-induced tumor suppression in a human endocrine pancreatic tumor cell line: Activation of the human mismatch repair protein 3 gene, BIOC BIOP R, 281(1), 2001, pp. 227-231
Citations number
29
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
281
Issue
1
Year of publication
2001
Pages
227 - 231
Database
ISI
SICI code
0006-291X(20010216)281:1<227:DECIPB>2.0.ZU;2-P
Abstract
Phospholipase C beta3 (PLCB3) is located to chromosome 11q13 in the vicinit y of the multiple endocrine neoplasia type1 (MEN1) gene and shows loss of e xpression in some neuroendocrine tumors. Transfection of PLCB3 to neuroendo crine cell lines induces growth suppression and phenotypic alterations, but the mechanisms remain unclear. To investigate the underlying events behind this tumor suppression, we performed an RT-Differential cDNA Display of to tal RNA from BON-1 (human endocrine pancreatic tumor cell line) transfected with PLCB3 and compared to wild type and BON-1 transfected with vector wit hout insert. PLCB3 transfection resulted in increased expression of 4 genes and decreased of 2. The two inhibited were homologous to S100A3 and Chromo granin A. One of the four activated cDNAs could be identified as human mism atch repair protein 3 mRNA (hMSH3), and another was homologous to TIS/MA-3 mRNA (mouse topoisomerase suppressor inhibited gene/mouse apoptosis gene-3) . Differential expression of these genes may contribute to the PLCB3-induce d tumor suppression of neuroendocrine tumor cell lines. (C) 2001 Academic P ress.